| Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies M Hidalgo, LL Siu, J Nemunaitis, J Rizzo, LA Hammond, C Takimoto, ... Journal of clinical oncology 19 (13), 3267-3279, 2001 | 1234 | 2001 |
| Tumour heterogeneity in the clinic PL Bedard, AR Hansen, MJ Ratain, LL Siu Nature 501 (7467), 355-364, 2013 | 1201 | 2013 |
| Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of … D Soulieres, NN Senzer, EE Vokes, M Hidalgo, SS Agarwala, LL Siu Journal of clinical oncology 22 (1), 77-85, 2004 | 974 | 2004 |
| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 963 | 2017 |
| Dose escalation methods in phase I cancer clinical trials C Le Tourneau, JJ Lee, LL Siu JNCI: Journal of the National Cancer Institute 101 (10), 708-720, 2009 | 857 | 2009 |
| The statins as anticancer agents KKW Chan, AM Oza, LL Siu Clinical cancer research 9 (1), 10-19, 2003 | 730 | 2003 |
| Toward understanding and exploiting tumor heterogeneity AA Alizadeh, V Aranda, A Bardelli, C Blanpain, C Bock, C Borowski, ... Nature medicine 21 (8), 846-853, 2015 | 682 | 2015 |
| Deintensification candidate subgroups in human papillomavirus–related oropharyngeal cancer according to minimal risk of distant metastasis B O'Sullivan, SH Huang, LL Siu, J Waldron, H Zhao, B Perez-Ordonez, ... Journal of Clinical Oncology 31 (5), 543-550, 2013 | 632 | 2013 |
| Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials CA Townsley, R Selby, LL Siu Journal of clinical oncology 23 (13), 3112-3124, 2005 | 624 | 2005 |
| Tumour-and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review L Khoja, D Day, TWW Chen, LL Siu, AR Hansen Annals of Oncology 28 (10), 2377-2385, 2017 | 601 | 2017 |
| Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong … AWM Lee, WH Lau, SY Tung, DTT Chua, R Chappell, L Xu, L Siu, ... Journal of Clinical Oncology 23 (28), 6966-6975, 2005 | 601 | 2005 |
| Randomized trial of radiotherapy plus concurrent–adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma AWM Lee, SY Tung, DTT Chua, RKC Ngan, R Chappell, R Tung, L Siu, ... Journal of the National Cancer Institute 102 (15), 1188-1198, 2010 | 399 | 2010 |
| Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas SH Huang, W Xu, J Waldron, L Siu, X Shen, L Tong, J Ringash, A Bayley, ... J Clin Oncol 33 (8), 836-845, 2015 | 396 | 2015 |
| Molecular profiling for precision cancer therapies ER Malone, M Oliva, PJB Sabatini, TL Stockley, LL Siu Genome medicine 12 (1), 1-19, 2020 | 381 | 2020 |
| Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial JJ Knox, D Hedley, A Oza, R Feld, LL Siu, E Chen, M Nematollahi, ... Journal of Clinical Oncology 23 (10), 2332-2338, 2005 | 378 | 2005 |
| A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas I Duran, J Kortmansky, D Singh, H Hirte, W Kocha, G Goss, L Le, A Oza, ... British journal of cancer 95 (9), 1148-1154, 2006 | 371 | 2006 |
| Impact of the media and the internet on oncology: survey of cancer patients and oncologists in Canada X Chen, LL Siu Journal of Clinical Oncology 19 (23), 4291-4297, 2001 | 368 | 2001 |
| Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with … M Moore, HW Hirte, L Siu, A Oza, SJ Hotte, O Petrenciuc, F Cihon, ... Annals of oncology 16 (10), 1688-1694, 2005 | 361 | 2005 |
| Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma W Shi, H Kato, B Perez-Ordonez, M Pintilie, S Huang, A Hui, B O'Sullivan, ... Journal of Clinical Oncology 27 (36), 6213-6221, 2009 | 354 | 2009 |
| Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier? KWL Yee, JL Pater, L Pho, B Zee, LL Siu Journal of Clinical Oncology 21 (8), 1618-1623, 2003 | 353 | 2003 |
